Genetic study of alpha thalassemia in children
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial looks at the genetic profiles of children with suspected alpha thalassemia, a type of inherited anemia. It aims to better understand this condition in children treated at Sohag University Hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 0 and 18 years old
- You have symptoms or lab results that suggest alpha thalassemia
- Your anemia is not caused by iron deficiency or beta thalassemia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a research registry collecting information about people with alpha thalassemia to support ongoing studies. It may help the team better understand how fetal stem cell treatments are working and for whom they may be most suitable.
This study looks at how severe thalassemia is in children and teens. If your child has thalassemia and is between 18 months and 18 years old, joining may help doctors better understand the condition.
This study looks at how your genes can affect inherited blood conditions like sickle cell disease and thalassemia. It may help researchers understand why symptoms differ from person to person, which could guide better future treatments.
This early-phase trial studies HGI-002 to see if it’s safe and can help people with severe alpha thalassemia who need frequent blood transfusions. It also requires planning for a special treatment approach that includes busulfan pre-treatment and stem cell transplantation.
This trial tests a one-time gene therapy using your own stem cells to help you produce healthy red blood cells and reduce or eliminate the need for regular blood transfusions. It is for people with transfusion-dependent beta-thalassemia who are between 3 and 35 years old.
This trial tests a new gene therapy (BD211) for children and teens with severe beta-thalassemia who need regular blood transfusions. The treatment uses your own blood stem cells, modified with a working gene, to help your body make healthy red blood cells and reduce the need for transfusions.
Hear when a new Alpha-Thalassemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.